Overview

Early Clinical Evaluation of the Pharmacokinetics and Mechanism Based Pharmacodynamics of Haloperidol Using Positron Emission Tomography in Healthy Volunteers

Status:
Completed

Trial end date:
2012-01-01

Target enrollment:

Participant gender:

Summary

In the present study, the investigators will establish the clinical trial technology for early evaluation of drug characteristics in terms of pharmacokinetics and pharmacodynamics for haloperidol as a model drug, using positron emission tomography.

Phase:

Phase 1

Details

Lead Sponsor:

Asan Medical Center

Collaborator:

Seoul National University Hospital

Treatments:

Haloperidol
Haloperidol decanoate